IVIG (intravenous immunoglobulin) is a medical treatment where concentrated antibodies collected from thousands of blood plasma donors are infused directly into your bloodstream through an IV line. It’s used to treat a wide range of conditions, from immune deficiencies where the body can’t produce enough of its own antibodies to autoimmune disorders where the immune system attacks healthy tissue. A typical infusion session lasts several hours, and depending on your condition, you may need treatments every few weeks on an ongoing basis.
What IVIG Is Made From
IVIG is derived from human blood plasma. Manufacturing facilities pool plasma from a large number of donors and extract the immunoglobulin G (IgG), the most abundant type of antibody in the blood. Because the product comes from so many different people, it contains a broad spectrum of antibodies that collectively represent exposure to countless viruses, bacteria, and other threats the donors encountered throughout their lives.
Safety during manufacturing is a major concern since the product originates from human blood. Manufacturers use multiple steps to eliminate viruses and other pathogens. These include heat treatment at 60°C for 10 hours, chemical treatments that dissolve the outer coating of viruses, and advanced filtration methods. These layered precautions make modern IVIG products extremely safe from a contamination standpoint.
Conditions Treated With IVIG
IVIG serves two broad purposes, and the dose you receive depends on which one applies to you.
For people with primary immunodeficiency diseases (conditions where the body doesn’t make enough antibodies on its own), IVIG acts as replacement therapy. It supplies the antibodies your immune system can’t produce, helping you fight off infections. Standard replacement doses typically range from 0.4 to 0.8 grams per kilogram of body weight per month.
For autoimmune and inflammatory conditions, IVIG works differently. At higher doses, often around 2 grams per kilogram, it helps calm an overactive immune system. It’s used in neurological conditions like chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy, as well as in certain blood disorders and inflammatory diseases. In some acute, life-threatening conditions like toxic epidermal necrolysis (a severe skin reaction), doses can go as high as 3 grams per kilogram over several days. Maintenance doses for neurological conditions often settle around 1 gram per kilogram per month once the condition stabilizes.
How the Infusion Works
IVIG is given through a needle placed into a vein, usually in your arm, in a hospital, infusion center, or sometimes at home with a trained nurse. The process is gradual and carefully controlled. Infusions start at a slow rate for the first 15 to 30 minutes so medical staff can watch for reactions. If you tolerate the initial flow well, the rate is increased every 15 to 30 minutes until it reaches a comfortable maximum speed.
A full session commonly takes anywhere from 2 to 6 hours depending on the dose, the product used, and how well you tolerate faster rates. First-time infusions tend to run longer because the rate is kept conservative. Over time, as your body shows it handles the treatment well, sessions can sometimes be shortened. Many patients bring books, laptops, or other activities to pass the time. You’ll typically have your vital signs checked at intervals throughout the process.
Common Side Effects
Headache is the most frequent side effect, affecting more than half of patients who receive IVIG. It can range from mild to severe and sometimes persists for a day or two after the infusion. Other common reactions include chills, fatigue, nausea, muscle aches, and low-grade fever. These tend to be worst during or shortly after the infusion and improve on their own.
To reduce the chance of side effects, many infusion centers will have you drink plenty of fluids beforehand and may give you pain relievers or antihistamines before the infusion starts. Staying well hydrated in the days surrounding your treatment is one of the simplest things you can do to minimize symptoms, particularly headaches.
Serious but Rare Risks
Blood clots are the most significant serious risk associated with IVIG. Estimates of how often they occur vary widely, from about 1% to nearly 17% of patients depending on the study and the population being treated. A large review of nearly 12,000 patients found that roughly 1% experienced a clot-related event. Higher rates have been reported in smaller studies of patients who may have had additional risk factors like older age, a history of blood clots, or conditions that make blood more likely to clot.
Other rare but serious complications include kidney injury (particularly in people with pre-existing kidney problems), severe allergic reactions, and aseptic meningitis, a type of brain lining inflammation that causes intense headache, neck stiffness, and sensitivity to light. Your medical team will screen for risk factors before starting treatment and monitor you closely during infusions.
IVIG vs. Subcutaneous Immunoglobulin
For some conditions, particularly immune deficiencies, there’s an alternative way to receive immunoglobulin: subcutaneous infusion (SCIG). Instead of going into a vein, smaller amounts are infused just under the skin using a small needle, often in the abdomen or thigh. SCIG is typically given weekly at home, compared to IVIG’s every-3-to-4-week schedule at an infusion center.
The trade-off is practical. SCIG gives you more independence and avoids the need for IV access, but it requires more frequent self-administered sessions and can cause localized skin reactions like redness and swelling at the injection site. IVIG delivers larger doses less often but requires dedicated time at a medical facility and carries a somewhat different side effect profile. Not every condition is appropriate for subcutaneous dosing, so the choice depends on your diagnosis, your lifestyle, and how your body responds to treatment.
What to Expect Long Term
For people with immune deficiencies, IVIG is often a lifelong treatment. Your antibody levels are monitored with regular blood tests, and your dose may be adjusted over time based on how well you fight off infections and what your blood levels show. For autoimmune conditions, some patients eventually taper off IVIG as their disease improves, while others need it indefinitely.
The cost of IVIG is substantial because it’s a biological product derived from human plasma, and doses are calculated by body weight. Insurance coverage varies, and prior authorization is commonly required. Many infusion centers have financial counselors who can help navigate the approval process. If you’re starting IVIG, it’s worth understanding your coverage early, since treatment costs can accumulate quickly with monthly infusions.